5 Companies
Psychedelic Companies Researching Depression
Psilocybin and other psychedelics have shown remarkable results for treatment-resistant depression, with several companies advancing Phase 2 and Phase 3 trials. The FDA has granted Breakthrough Therapy Designation to multiple compounds for depression.
Trial pipeline:
2 Phase 1
4 Phase 2
1 Phase 3+
7 total trials